Assess weight loss or exercise to improve heart function in diabetes
Part of Hormones & metabolism clinical trials.
This study tests whether slimming (weight loss) or training (exercise) can improve early, “hidden” heart and blood-vessel problems in people with type 2 diabetes. It may help find a safer way to protect the heart by improving risk factors.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can understand the study and sign consent before any study steps
- You have type 2 diabetes diagnosed at age under 60
- You’re 18 to 65 years old
- Your blood sugar control is not too high (HbA1c up to 9–10% depending on your treatment)
- You either take diabetes medicines now or have diet-controlled diabetes with higher HbA1c and a BMI in the eligible range
- You can do exercise/activities required by the study and are able to have a heart scan (CMR) if needed
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether high-intensity interval training (short bursts of intense exercise) helps people who have reversed their type 2 diabetes stay in remission. Researchers want to see if this type of exercise is safe and effective for maintaining diabetes-free status.
This study compares different diabetes medicines to see which works best for people with type 2 diabetes who also have heart or blood vessel risks. It aims to find better treatment to protect your heart and kidneys.
This study tests whether high-intensity interval training can improve how your body uses insulin. It is for people with type 2 diabetes who are not on insulin and have had diabetes for 1 to 5 years.
This study tests whether reducing liver fat can improve health in people with type 2 diabetes. It looks at the effects of a specific medication combined with exercise, tailored for those who are not very active.
This Phase 4 trial studies an approach to help prevent heart problems in adults with type 2 diabetes who are at higher heart risk. It may help reduce future cardiovascular events by testing medications for safety and benefit in this group.
This study tests whether a new medicine called NNC0487-0111 helps people with type 2 diabetes and excess weight lose weight. You'll take the medicine along with your current diabetes care to see if it works better than standard treatment.
Hear when a new Diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.